# Factors Determining the Prognosis in NSCLC Stage IV

> **NCT04306094** · — · UNKNOWN · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 217 (estimated)

## Conditions studied

- NSCLC Stage IV

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04306094
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-02-01
- **Target enrollment:** 217 (ESTIMATED)
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04306094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04306094, "Factors Determining the Prognosis in NSCLC Stage IV". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04306094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*